Literature DB >> 18629591

Depression and screening cardiovascular events.

Kim G Smolderen, Annelies E Aquarius, Johan Denollet.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18629591      PMCID: PMC2518014          DOI: 10.1007/s11606-008-0696-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
To the Editor: —Peripheral arterial disease (PAD) remains an under-treated disease1, and information about risk factors and prognosis is poorly disseminated in the population2. Nevertheless, PAD and coronary artery disease (CAD) patients share the same risk factors, and risks of future cardiovascular events in PAD patients are comparable with those in CAD patients3. Depression may adversely impact prognosis in CAD patients4, but little is known about depression and prognosis in PAD. Therefore, we read with great interest the work of Cherr and colleagues5 on the relation between psychological factors and cardiovascular events in PAD. Their study generated interesting findings, but there are also a number of issues we would like to address here. First, the screening method the authors used probably led to an overestimation of depression rates. The General Health Questionnaire is not a depression scale, but rather was developed to assess non-specific psychological distress in community samples6, and a higher cut-off score (≥8) has been recommended to screen for depressive symptoms in patients with chronic somatic disease7. Second, 80% of depressed patients received antidepressant therapy. Analyses were not adjusted for type of antidepressant, while studies warn against the use tricyclic antidepressants in cardiovascular populations because they are associated with an increased risk of myocardial infarction8,9. Therefore, we cannot rule out the influence of antidepressant use on adverse outcomes in depressed patients. Finally, in the adjusted analyses, only a rough parameter of disease severity was included (indication for intervention). Table 2 shows us that the group that underwent revascularization was very heterogeneous in terms of disease severity; indication for intervention ranged from claudication to critical leg ischemia and gangrene or tissue loss. It would have been more appropriate to include the lowest ankle-brachial index in the adjusted analyses due to its strong prognostic value for adverse cardiovascular events in PAD10. Likewise, in CAD, the relation between depression and increased risk of mortality seems to be confounded by cardiac disease severity or left ventricular dysfunction11. Future studies examining the link between psychological factors and prognosis in PAD need to take into account reliable indices of disease severity.
  11 in total

Review 1.  Critical issues in peripheral arterial disease detection and management: a call to action.

Authors:  Jill J F Belch; Eric J Topol; Giancarlo Agnelli; Michel Bertrand; Robert M Califf; Denis L Clement; Mark A Creager; J Donald Easton; James R Gavin; Philip Greenland; Graeme Hankey; Peter Hanrath; Alan T Hirsch; Jürgen Meyer; Sidney C Smith; Frank Sullivan; Michael A Weber
Journal:  Arch Intern Med       Date:  2003-04-28

2.  Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12.

Authors:  Martin Härter; Sonja Woll; Alexandra Wunsch; Jürgen Bengel; Katrin Reuter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-01       Impact factor: 4.328

3.  Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey.

Authors:  Alan T Hirsch; Timothy P Murphy; Marge B Lovell; Gwen Twillman; Diane Treat-Jacobson; Eileen M Harwood; Emile R Mohler; Mark A Creager; Robert W Hobson; Rose Marie Robertson; W James Howard; Paul Schroeder; Michael H Criqui
Journal:  Circulation       Date:  2007-09-17       Impact factor: 29.690

4.  The long-term prognostic value of the resting and postexercise ankle-brachial index.

Authors:  Harm H H Feringa; Jeroen J J Bax; Virginie H van Waning; Eric Boersma; Abdou Elhendy; Olaf Schouten; Marco J Tangelder; Marc H R M van Sambeek; Anton H van den Meiracker; Don Poldermans
Journal:  Arch Intern Med       Date:  2006-03-13

5.  Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT.

Authors:  Joost P van Melle; Peter de Jonge; Johan Ormel; Harry J G M Crijns; Dirk J van Veldhuisen; Adriaan Honig; Aart H Schene; Maarten P van den Berg
Journal:  Eur Heart J       Date:  2005-09-05       Impact factor: 29.983

6.  Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.

Authors:  H W Cohen; G Gibson; M H Alderman
Journal:  Am J Med       Date:  2000-01       Impact factor: 4.965

7.  Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.

Authors:  Joost P van Melle; Peter de Jonge; Titia A Spijkerman; Jan G P Tijssen; Johan Ormel; Dirk J van Veldhuisen; Rob H S van den Brink; Maarten P van den Berg
Journal:  Psychosom Med       Date:  2004 Nov-Dec       Impact factor: 4.312

8.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 9.  Coronary artery disease and depression.

Authors:  Michael J Zellweger; Remo H Osterwalder; Wolf Langewitz; Matthias E Pfisterer
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

10.  Patients with depression are at increased risk for secondary cardiovascular events after lower extremity revascularization.

Authors:  Gregory S Cherr; Pamela M Zimmerman; Jiping Wang; Hasan H Dosluoglu
Journal:  J Gen Intern Med       Date:  2008-02-26       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.